Skip to main content
. 2022 Feb 15;17(2):e0263829. doi: 10.1371/journal.pone.0263829

Fig 5. Pharmacologic targeting of PKA with H89 and Hsp40 with KNK437 results in downregulation of LINC00473 in HEK-DP cells.

Fig 5

(a) H89 treatment of A9 and A11 clones demonstrates decreased expression of LINC00473 (TV1); (b) H89 treatment of A9 and A11 clones demonstrates decreased expression of LINC00473 (TV2); (c-d) KNK437 treatment results in decreased expression of LINC00473 TV1 and TV2. (*p<0.05;**p<0.01; ***p<0.001; ****p<0.0001).